Reporting owner · CIK 0002045377
Sun Nelson
Visual SEC Form 4 history across 1 companies, 6 transactions and 3 filings.
SRSee RemarksAardvark Therapeutics, Inc.
Open-market mix
33%buys
Open-market buy performance
90-day forward return on this insider's open-market purchases
Forward return is not available yet
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for some of their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Buys Sells
Net value flow
Buys minus sells
Feb 25
$160K
Feb 26
$0
Sep 26
−$395K
Transaction texture
Ownership and ticket size
Average P/S size$185K
Median P/S size$160K
Direct6
Indirect0
Sep 11, 2026sale
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
Latest transaction
sale at Aardvark Therapeutics, Inc. on Sep 11, 2026 valued at $321,179.
Review SEC filingAssociated companies
Visual map of known reporting history
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| AARD | Sun Nelson | SR | sale10b5-1 | 62.0k | -$32.1M | S | 0.0% | 09/12 | 09/11 | |
| AARD | Sun Nelson | SR | sale10b5-1 | 14.7k | -$7.37M | S | 0.0% | 09/12 | 09/10 | |
| AARD | Sun Nelson | CFO | grant | 70.5k | $0 | A | −46.3% | 02/12 | 02/09 | |
| AARD | Sun Nelson | CFO | C | 59.3k | $0 | C | — | 02/19/2025 | 02/14/2025 | |
| AARD | Sun Nelson | CFO | buy | 10.0k | $16.0M | P | — | 02/19/2025 | 02/14/2025 | |
| AARD | Sun Nelson | CFO | C | 7.00k | — | C | — | 02/19/2025 | 02/14/2025 |
Sun Nelson Insider Activity FAQ
SEC Form 4 context
Who is Sun Nelson?
Sun Nelson is a reporting owner in SEC Form 4 filings with reporting owner CIK 0002045377.
Which companies has Sun Nelson reported transactions for?
Aardvark Therapeutics, Inc.
When was Sun Nelson's latest insider buy?
buy at Aardvark Therapeutics, Inc. on Feb 14, 2025 valued at $160,000.
When was Sun Nelson's latest insider sale?
sale at Aardvark Therapeutics, Inc. on Sep 11, 2026 valued at $321,179.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.